ReviewPatient preference and adherence2015

Teriflunomide for the treatment of relapsing-remitting multiple sclerosis: patient preference and adherence.

Antonios Bayas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.